Thrombosis
Showing 9951 - 9975 of >10,000
CHRONIC MYELOGENOUS LEUKEMIA Trial in Worldwide (Nilotinib, Imatinib)
Completed
- CHRONIC MYELOGENOUS LEUKEMIA
-
Caba, Buenos Aires, Argentina
- +29 more
Oct 4, 2016
Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation Trial in Worldwide (Lumacaftor Plus Ivacaftor
Completed
- Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
- Lumacaftor Plus Ivacaftor Combination
- Ivacaftor
-
Birmingham, Alabama
- +166 more
Apr 3, 2017
Opioid Induced Bowel Dysfunction Trial in Salt Lake City (Naldemedine, Placebo)
Completed
- Opioid Induced Bowel Dysfunction
- Naldemedine
- Placebo
-
Salt Lake City, UtahShionogi Research Site
Apr 19, 2017
Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (alemtuzumab)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- alemtuzumab
-
Cullman, Alabama
- +175 more
May 2, 2017
Coronary Artery Disease, Stent Thrombosis, Myocardial Ischemia Trial in Paris (Aspirin and Clopidogrel, Aspirin)
Completed
- Coronary Artery Disease
- +2 more
- Aspirin and Clopidogrel
- Aspirin
-
Paris, FranceHopital la Pitié Salpêtrière Institut de Cardiologie
Oct 16, 2014
Prostate Cancer Trial in United States (Degarelix, Leuprolide)
Completed
- Prostate Cancer
-
Alexander City, Alabama
- +58 more
Oct 21, 2016
Osteoarthritis, Knee Trial in Koahsiung (Topical tranexamic acid, Floseal®, Enoxaparin)
Unknown status
- Osteoarthritis, Knee
- Topical tranexamic acid
- +2 more
-
Koahsiung, TaiwanKaohsiung Chang Gung Memorial Hospital
Aug 9, 2016
Anemia Trial in United States (methoxy polyethylene glycol-epoetin beta [Mircera])
Completed
- Anemia
- methoxy polyethylene glycol-epoetin beta [Mircera]
-
Birmingham, Alabama
- +13 more
Oct 26, 2016
Venous Thrombosis, Insulin Resistance Trial in London (Femoston Conti, EVOREL® CONTI)
Unknown status
- Venous Thrombosis
- Insulin Resistance
- Femoston Conti
- EVOREL® CONTI
-
London, United Kingdom
- +2 more
Oct 14, 2014
Inflammation, Infection, and Future Cardiovascular Risk
Completed
- Cardiovascular Diseases
- +11 more
- (no location specified)
Mar 15, 2016
Thrombotic, Inflammatory & Gene Markers of CVD in Women
Completed
- Cardiovascular Diseases
- +3 more
- (no location specified)
Mar 15, 2016
Anemia Trial in Worldwide (epoetin alfa or beta, methoxy polyethylene glycol-epoetin beta (Mircera))
Completed
- Anemia
- epoetin alfa or beta
- methoxy polyethylene glycol-epoetin beta (Mircera)
-
Hot Springs, Arkansas
- +89 more
Apr 26, 2016
Burns Trial in Ft Sam Houston (Recombinant Factor VIIa, Placebo)
Completed
- Burns
- Recombinant Factor VIIa
- Placebo
-
Ft Sam Houston, TexasUnited States Army Institute of Surgical Research
Apr 26, 2016
Anemia Trial in Hungary (Methoxy polyethylene glycol-epoetin beta)
Completed
- Anemia
- Methoxy polyethylene glycol-epoetin beta
-
Baja, Hungary
- +9 more
Feb 16, 2016
Venous Thrombosis Trial in Galway (Neuromuscular electrical stimulator, AV Impulse System Model 6000)
Completed
- Venous Thrombosis
- Neuromuscular electrical stimulator
- AV Impulse System Model 6000
-
Galway, IrelandNational University of Ireland, Galway
Sep 2, 2014
Bacterial Infections Trial in Montreal (Follow up of complications)
Completed
- Bacterial Infections
- Follow up of complications
-
Montreal, Quebec, Canada
- +1 more
Mar 14, 2016
Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM) Trial in Worldwide (Everolimus (RAD001), Everolimus Placebo)
Completed
- Tuberous Sclerosis Complex (TSC)
- Lymphangioleiomyomatosis (LAM)
- Everolimus (RAD001)
- Everolimus Placebo
-
Birmingham, Alabama
- +24 more
Jan 3, 2017
Major Bleeding Events in Atrial Fibrillation Patients Using
Completed
- Atrial Fibrillation
- Hemorrhage
- Dabigatran 75 mg
- Dabigatran 150 mg
-
Boston, Massachusetts
- +4 more
Mar 3, 2016
Prostatic Hyperplasia Trial in Worldwide (dutasteride 0.5mg once daily for 4 years, tamsulosin 0.4mg once daily for 4 years)
Completed
- Prostatic Hyperplasia
- dutasteride 0.5mg once daily for 4 years
- tamsulosin 0.4mg once daily for 4 years
-
Birmingham, Alabama
- +503 more
Jan 16, 2017
Coronary Artery Disease Trial in Baltimore (Prasugrel, Ticagrelor)
Unknown status
- Coronary Artery Disease
-
Baltimore, MarylandSinai Center for Thrombosis Research
Nov 20, 2014
Pulmonary Tuberculosis Trial in Cape Town (TMC207 (J), PA-824 (PA), pyrazinamide (Z))
Completed
- Pulmonary Tuberculosis
- TMC207 (J)
- +4 more
-
Cape Town, South Africa
- +1 more
Oct 19, 2016